Cannabi Biotech, known as a NSTDA Startup Company joint-ventured between Cannabi Biosciences (Hong Kong, China) and National Science and Technology Development Agency (NSTDA), aims to focus on the latest innovation in biorefinery, health sciences and drug discovery. Cannabi Biotech has attracted investment from China in strengthening the science and innovation exchange, marketing and economic collaboration between Thailand and China. Recently, Cannabi Biotech has financially supported several research projects for National Center for Genetic Engineering and Biotechnology (BIOTEC) and National Center for Nanotechnology (NANOTEC).

Cannabi Biotech has also assisted Thai small and mid-size enterprises (SMEs) for promoting a marketing collaboration at the international level through Northern Science Park-Naresuan University-The Federal of Thailand Industries (FTI). Cannabi Biotech and Cannabi Biosciences have agreed to establish a joint venture company in 2022, ‘CannaVivid’, with Vivid Korea, as a leading healthcare beauty company in ASEAN to focus on a beauty and anti-ageing clinic promoting Thailand as a medical hub of the world. To strengthen the atomization technology, the collaboration between Waza International Group, Cannabi Biotech and National Center for Genetic Engineering and Biotechnology (BIOTEC) aims to promote the technological transfer, marketing collaboration and investment in atomization between Thailand and China to the world.